4//SEC Filing
Wright Medical Group N.V. 4
Accession 0001235802-16-000291
CIK 0001492658operating
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:47 PM ET
Size
7.6 KB
Accession
0001235802-16-000291
Insider Transaction Report
Form 4
Griffin William L. Jr
SVP GM BioMimetic Therapeutics
Transactions
- Award
Stock Option (right to buy)
2016-07-19+28,197→ 28,197 totalExercise: $21.24Exp: 2026-07-19→ Ordinary Shares (28,197 underlying) - Award
Ordinary Shares, par value EUR 0.03 per share
2016-07-19+9,812→ 85,490 total
Footnotes (3)
- [F1]These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
- [F2]Includes 16,331 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan.
- [F3]This option vests with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeoperating
IncorporatedNetherlands
Related Parties
1- filerCIK 0001492658
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 5:47 PM ET
- Size
- 7.6 KB